Scot A. Sullivan, M.D.

Dr. Scot Sullivan has been in full-time practice as an oculofacial plastic surgeon since 2001. He received his medical degree with special distinction from the University of Oklahoma College of Medicine and finished near the top of his class earning him membership in the exclusive Alpha Omega Alpha (AOA) honor society. Following his General Surgery internship at Vanderbilt University Medical Center, he completed his ophthalmology residency at the University of Oklahoma where he was awarded the Dr. and Mrs. Thomas E. Acers Resident Honor Award for Scientific Achievement.

He concluded his academic training at the Casey Eye Institute at OHSU where he was recognized with the top research award among all graduating fellows nationwide by the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS). He served as a Clinical Assistant Professor in the University of Oklahoma ophthalmology program residency for 5 years before returning to Portland to establish Portland Oculoplastics.

Dr. Sullivan is a member of the American Academy of Ophthalmology (AAO) and the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) and and served on the executive board of the Oregon Academy of Ophthalmology (OAO) from 2010 to 2021. He has authored numerous publications in peer-review journals and has delivered a variety of educational lectures.

During the emergence of widespread use of Botox in medical practice, he was invited to author the inaugural on-line course by the American Academy of Ophthalmology titled “The Use of Botulinum Toxin (BTX) in Ophthalmic Practice” which he co-authored with his mentor Dr. Roger Dailey in 2003.

Dr. Sullivan grew up in Norman, Oklahoma and is a third generation doctor from a family with a rich tradition in the healing arts. In his free time, he pursues his passions as a competitive masters swimmer and avid cyclist, attends football games of his alma mater with college friends and enjoys the natural beauty and cultural offerings of our wonderful city of Portland, Oregon.

 

EDUCATION/TRAINING

  • M.D. – University of Oklahoma College of Medicine
  • Internship, General Surgery: Vanderbilt University Medical Center
  • Residency, Ophthalmology: Dean McGee Eye Institute, University of Oklahoma
  • Fellowship, Ophthalmic Facial Plastic and Reconstructive Surgery: Casey Eye Institute, OHSU

MEDICAL STAFF APPOINTMENTS

  • Providence St. Vincent Medical Center, Portland, Oregon
  • Wilshire Surgery Center, Portland, Oregon

PROFESSIONAL ASSOCIATIONS

  • American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS)
  • American Academy of Ophthalmology (AAO)
  • Oregon Academy of Ophthalmology (OAO)

SCIENTIFIC PUBLICATIONS

  • Othman MI, Sullivan SA, Skuta GL et al. Autosomal dominant nanophthalmos (NNO1) with high hyperopia and angle-closure maps to chromosome 11. American Journal of Human Genetics 03:1411-1418,1998.
  • Dailey RA, Sullivan SA, Wobig JL. Surgical debulking of eyelid and anterior orbital plexiform neurofibromas by means of the carbon dioxide laser.  Am J Ophthalmol 2000 Jul 1;130(1):117-119.
  • Sullivan SA, Dailey RA. Complications of laser resurfacing and their management. Ophthal Plast Reconstr Surg 2000 Nov;16(6):417-26.
  • Sullivan SA, Dailey RA. Endoscopic subperiosteal midface lift: surgical technique with indications and outcomes. Ophthal Plast Reconstr Surg. 2002 Sep;18(5):319-30; discussion 329-30.
  • Dailey RA, Saulny SM, Sullivan SA. Muller muscle-conjunctival resection: effect on tear production. Ophthal Plast Reconstr Surg 2002 Nov;18(6):421-5.
  • Sullivan SA, Dailey RA.  Graft contraction: a comparison of acellular dermis versus hard palate mucosa in lower eyelid surgery. Ophthal Plast Reconstr Surg 2003 Jan;19(1):14-24.
  • Sullivan SA, Dailey RA.  Botulinum toxin in ophthalmic practice.  American Academy of Ophthalmology On-line CME course. April, 2003.
  • Westfall AC, Mansoor A, Sullivan SA, Wilson DJ, Dailey RA. Orbital and periorbital myofibromas in childhood: two case reports. Ophthalmology. 2003 Oct;110(10):2000-5.
  • Garnai SJ, Brinkmeier ML, Emery B, Aleman TS, Pyle LC, Veleva-Rotse B, Sisk RA, Rozsa FW, Ozel AB, Li JZ, Moroi SE, Archer SM, Lin CM, Sheskey S, Wiinikka-Buesser L, Eadie J, Urquhart JE, Black GCM, Othman MI, Boehnke M, Sullivan SA, Skuta GL, Pawar HS, Katz AE, Huryn LA, Hufnagel RB; Genomic Ascertainment Cohort, Camper SA, Richards JE, Prasov L. Variants in myelin regulatory factor (MYRF) cause autosomal dominant and syndromic nanophthalmos in humans and retinal degeneration in mice. PLoS Genet. 2019 May 2;15(5):e1008130.

RESEARCH AWARDS

  • Dr. and Mrs. T.E. Acers Resident Honor Award for Scientific Achievement, June, 1998
  • American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) Annual Research award, presented November, 2003